Rational Design of Cell-Active Inhibitors of PARP10

ACS Medicinal Chemistry Letters
2019.0

Abstract

Poly-ADP-ribose polymerases (PARPs 1-16) have emerged as major regulators of diverse cellular processes. PARPs can be subclassified based on their ability to catalyze poly-ADP-ribosylation (PARylation) or mono-ADP-ribosylation (MARylation). While much is known about the cellular roles of PARPs that catalyze PARylation (e.g., PARP1), the function of PARPs that catalyze MARylation (e.g., PARP10) is substantially less understood. This is due in large part to the lack of small-molecule inhibitors that are selective for individual PARP family members that catalyze MARylation. Herein, we describe the rational design and synthesis of selective inhibitors of PARP10. Using structure-based design, we targeted a hydrophobic subpocket within the nicotinamide-binding site of PARP10. We synthesized a series of small molecules based on a 3,4-dihydroisoquinolin-1(2<i>H</i>)-one (dq, <b>1</b>) scaffold that contain various substituents at the C-5 and C-6 positions designed to exploit this hydrophobic subpocket. We found a dq analogue (<b>22</b>) that contains a methyl group at the C-5 position and a substituted pyridine at the C-6 position that exhibits >10-fold selectivity for PARP10 over a large subset of other PARP family members. The results of this study will serve as a platform for future small-molecule probe development for PARP10 and other PARP family members that catalyze MARylation.

Knowledge Graph

Similar Paper

Rational Design of Cell-Active Inhibitors of PARP10
ACS Medicinal Chemistry Letters 2019.0
Selective inhibition of PARP10 using a chemical genetics strategy
Bioorganic &amp; Medicinal Chemistry Letters 2015.0
Design, Synthesis, and Evaluation of 3,4-Dihydro-2H-[1,4]diazepino[6,7,1-hi]indol-1-ones as Inhibitors of Poly(ADP-Ribose) Polymerase
Journal of Medicinal Chemistry 2004.0
Synthesis and SAR optimization of quinazolin-4(3H)-ones as poly(ADP-ribose)polymerase-1 inhibitors
European Journal of Medicinal Chemistry 2012.0
Design, synthesis and biological evaluation of pyridazino[3,4,5-de]quinazolin-3(2H)-one as a new class of PARP-1 inhibitors
Bioorganic &amp; Medicinal Chemistry Letters 2015.0
Resistance-Modifying Agents. 5. Synthesis and Biological Properties of Quinazolinone Inhibitors of the DNA Repair Enzyme Poly(ADP-ribose) Polymerase (PARP)
Journal of Medicinal Chemistry 1998.0
Novel PARP-1 inhibitors based on a 2-propanoyl-3H-quinazolin-4-one scaffold
Bioorganic &amp; Medicinal Chemistry Letters 2014.0
The discovery and synthesis of novel adenosine substituted 2,3-dihydro-1H-isoindol-1-ones: potent inhibitors of poly(ADP-ribose) polymerase-1 (PARP-1)
Bioorganic &amp; Medicinal Chemistry Letters 2004.0
Modeling of Poly(ADP-ribose)polymerase (PARP) Inhibitors. Docking of Ligands and Quantitative Structure−Activity Relationship Analysis
Journal of Medicinal Chemistry 2001.0
Design, synthesis, and bioactivity study on Lissodendrins B derivatives as PARP1 inhibitor
Bioorganic &amp; Medicinal Chemistry 2022.0